Amgen, Merck, and Eli Lilly sue over Trump administration policy to require drug prices in TV ads
A trio of pharmaceutical manufacturers on Friday filed suit to overturn one of the most impactful drug pricing policies the Trump administration has enacted to date: a requirement that the companies include a medicine’s list price in direct-to-consumer advertising.
